These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8623674)

  • 1. Life-threatening anaphylactoid reaction after iv injection of gadoterate meglumine.
    Meuli RA; Maeder P
    AJR Am J Roentgenol; 1996 Mar; 166(3):729. PubMed ID: 8623674
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anaphylactoid reaction caused by intravenous gadopentetate dimeglumine in magnetic resonance].
    Campos A; Aznar L; Alamar R; Castelló JV
    Med Clin (Barc); 1996 Feb; 106(5):197. PubMed ID: 8684023
    [No Abstract]   [Full Text] [Related]  

  • 3. Life-threatening anaphylactoid reaction after intravenous gadoteridol administration in a patient who had previously received gadopentetate dimeglumine.
    Witte RJ; Anzai LL
    AJNR Am J Neuroradiol; 1994 Mar; 15(3):523-4. PubMed ID: 8197951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaphylactoid reactions to i.v. gadopentetate dimeglumine.
    Tishler S; Hoffman JC
    AJNR Am J Neuroradiol; 1990; 11(6):1167; discussion 1168-9. PubMed ID: 2124049
    [No Abstract]   [Full Text] [Related]  

  • 5. Anaphylactic shock after first exposure to a macrocyclic gadolinium chelate: a few comments.
    Idée JM; Corot C
    J Allergy Clin Immunol; 2008 Jul; 122(1):215-6; author reply 216-7. PubMed ID: 18547628
    [No Abstract]   [Full Text] [Related]  

  • 6. Fatal reaction to gadopentetate dimeglumine.
    Jordan RM; Mintz RD
    AJR Am J Roentgenol; 1995 Mar; 164(3):743-4. PubMed ID: 7863905
    [No Abstract]   [Full Text] [Related]  

  • 7. Anaphylactic shock induced by gadoterate meglumine (DOTAREM).
    Beaudouin E; Kanny G; Blanloeil Y; Guilloux L; Renaudin JM; Moneret-Vautrin DA
    Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):382-5. PubMed ID: 14768523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe adverse reactions with contrast agents for magnetic resonance: clinical experience in 30,000 MR examinations.
    De Ridder F; De Maeseneer M; Stadnik T; Luypaert R; Osteaux M
    JBR-BTR; 2001 Aug; 84(4):150-2. PubMed ID: 11688727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe adverse reaction to iv gadopentetate dimeglumine.
    Takebayashi S; Sugiyama M; Nagase M; Matsubara S
    AJR Am J Roentgenol; 1993 Mar; 160(3):659. PubMed ID: 8430574
    [No Abstract]   [Full Text] [Related]  

  • 10. Suspected anaphylactoid reaction following intravenous administration of a gadolinium-based contrast agent in three dogs undergoing magnetic resonance imaging.
    Girard NM; Leece EA
    Vet Anaesth Analg; 2010 Jul; 37(4):352-6. PubMed ID: 20636567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaphylactic shock induced by intravenous gadopentetate dimeglumine.
    Tardy B; Guy C; Barral G; Page Y; Ollagnier M; Bertrand JC
    Lancet; 1992 Feb; 339(8791):494. PubMed ID: 1346846
    [No Abstract]   [Full Text] [Related]  

  • 12. A Pharmacokinetics, Efficacy, and Safety Study of Gadoterate Meglumine in Pediatric Subjects Aged Younger Than 2 Years.
    Scala M; Koob M; de Buttet S; Bourrinet P; Felices M; Jurkiewicz E
    Invest Radiol; 2018 Feb; 53(2):70-79. PubMed ID: 28906338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse reaction to intravenous gadoteridol.
    Shellock FG; Hahn HP; Mink JH; Itskovich E
    Radiology; 1993 Oct; 189(1):151-2. PubMed ID: 8372186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal anaphylaxis caused by gadolinium due to beta-tryptase-induced hemorragic diathesis.
    Prieto-García A; Pérez-David E; Devesa C; Tornero P; Schwartz LB; Pascual C; Castells MC
    J Allergy Clin Immunol Pract; 2017; 5(5):1433-1434. PubMed ID: 28634099
    [No Abstract]   [Full Text] [Related]  

  • 15. Can gadolinium be safely given in renal failure?
    Weissleder R
    AJR Am J Roentgenol; 1996 Jul; 167(1):278-9. PubMed ID: 8659405
    [No Abstract]   [Full Text] [Related]  

  • 16. Gadoteridol-induced anaphylaxis - not a class allergy.
    Galera C; Pur Ozygit L; Cavigioli S; Bousquet PJ; Demoly P
    Allergy; 2010 Jan; 65(1):132-4. PubMed ID: 19796195
    [No Abstract]   [Full Text] [Related]  

  • 17. Anaphylactic shock after first exposure to gadoterate meglumine: two case reports documented by positive allergy assessment.
    Hasdenteufel F; Luyasu S; Renaudin JM; Paquay JL; Carbutti G; Beaudouin E; Moneret-Vautrin DA; Kanny G
    J Allergy Clin Immunol; 2008 Feb; 121(2):527-8. PubMed ID: 17919712
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety of gadoterate meglumine in children younger than 2 years of age.
    Farmakis SG; Hardy AK; Mahmoud SY; Wilson-Flewelling SA; Tao TY
    Pediatr Radiol; 2020 May; 50(6):855-862. PubMed ID: 32055917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and Severity of Acute Allergic-Like Reactions to Intravenously Administered Gadolinium-Based Contrast Media in Children.
    Forbes-Amrhein MM; Dillman JR; Trout AT; Koch BL; Dickerson JM; Giordano RM; Towbin AJ
    Invest Radiol; 2018 May; 53(5):313-318. PubMed ID: 29337841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anaphylactoid reaction after intravenous administration of Gd-DTPA].
    Katoh A; Kishikawa T; Kudo S; Matsubayashi R; Takagi N; Nishihara G
    Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Aug; 53(8):973-5. PubMed ID: 8371946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.